Hepatitis C Virus NS5A Inhibitor
8 drugs across 4 manufacturers|1 Generic,7 Brand
Total Drugs
8
1G / 7B
Manufacturers
4
Avg $524.3457/unit
Avg 7d Change
-0.03%
Across 5 drugs with changes
7d Activity
1↑4↓3 flat
of 8 total drugs
Class Price Trend
Monthly average NADAC price per unit, split by generic and brand
Manufacturer Breakdown
4 manufacturers producing drugs in this therapeutic class
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
HARVONI 90-400 MG TABLET LEDIPASVIR and SOFOSBUVIR | $1098.9375 per EA | — |
EPCLUSA 400 MG-100 MG TABLET Velpatasvir and Sofosbuvir | $866.0738 per EA | -0.13% |
VOSEVI 400-100-100 MG TABLET SOFOSBUVIR, VELPATASVIR, and VOXILAPREVIR | $858.6884 per EA | — |
ZEPATIER 50-100 MG TABLET elbasvir and grazoprevir | $634.2375 per EA | — |
SOFOSBUVIR-VELPATASVIR 400-100 Velpatasvir and Sofosbuvir | $278.3271 per EA | +0.06% |
MAVYRET 100-40 MG TABLET Glecaprevir and Pibrentasvir | $152.8336 per EA | -0.02% |
MAVYRET 100-40 MG TABLET Glecaprevir and Pibrentasvir | $152.8336 per EA | -0.02% |
MAVYRET 100-40 MG TABLET Glecaprevir and Pibrentasvir | $152.8336 per EA | -0.02% |